SCHEMBL626217

SCHEMBL626217

O=S(=O)(CC1CC1)N1CCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 5/20 0.42
JAK1 P23458 5/20 0.42
JAK3 P52333 5/20 0.42
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
TSHR P16473 2/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 1/20 0.34
SMYD3 Q9H7B4 2/20 0.34
GRM5 P41594 1/20 0.34
SLC6A9 P48067 2/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14836906 0.93 CA1 (0.42) JAK2JAK1JAK3PSEN1PSEN2
SCHEMBL13013205 0.88 GRM5 (0.39) JAK2JAK1JAK3PSEN1PSEN2
SCHEMBL8125415 0.86 CHRM5 (0.41) JAK2JAK1JAK3PSEN1PSEN2
SCHEMBL16439623 0.80 KDM4E (0.42) JAK2JAK1JAK3TSHRKMT2A
SCHEMBL22642399 0.80 JAK2 (0.36) JAK2JAK1JAK3SMYD3SLC6A9
SCHEMBL24477631 0.80 KDM4E (0.49) JAK2JAK1JAK3TSHRKMT2A
SCHEMBL2424805 0.80 JAK2 (0.46) JAK2JAK1JAK3SMYD3
SCHEMBL18712872 0.80 JAK2 (0.46) JAK2JAK1JAK3KMT2ASMYD3
Hydrochloric Acid SCHEMBL27074827 0.79 KDM4E (0.41) JAK2JAK1JAK3TSHRKMT2A
SCHEMBL2424972 0.77 JAK2 (0.42) JAK2JAK1JAK3PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603481-A2 AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY Abbott GmbH & Co. KG (DE) 2013-06-19 EP claimed
WO-2012020131-A2 AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO. KG (DE) 2012-02-16 WO claimed
EP-2603481-A2 AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY Abbott GmbH & Co. KG (DE) 2013-06-19 EP disclosed
WO-2012020131-A2 AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO. KG (DE) 2012-02-16 WO disclosed